Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.
This is an ingested summary. Full reporting is available at the primary source below.